Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by wyndeweston Jul 27, 2021 11:44am
61 Views
Post# 33610156

Thomvest could fix this

Thomvest could fix thisThey just have to do another reverse stock split like they did with Prometic (1 for 1000 shares).  HA HA!  BUT why would Peter Thomson bother?  He has already moved the intellectual property rights to his private account in the Cayman Islands.  There's not much left  in this company so why bother.  Shareholder's are being left with an 'empty suitcase'.  I wonder how the poor sods that bought the 'rights offer' are feeling now? Somewhat devasted I would imagine....
<< Previous
Bullboard Posts
Next >>